Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-16-146208

Chief Operating Officer sold 483 shares at $2.45 ($1,184)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keuer Thomas A Chief Operating Officer 2016-10-18 Sale −483 $2.45 $1,184 14,900 D
Open-market sales · 483 sh · avg $2.45 · $1,184
Loading xslF345X03/doc4.xml…